Inspire names Adams CEO

Ophthalmic and pulmonary company Inspire Pharmaceuticals Inc. (NASDAQ:ISPH) hired Adrian Adams as president, CEO and a director. Adams was formerly president and CEO of Sepracor Inc., which was acquired by Dainippon Sumitomo Pharma Co. Ltd. (Tokyo:4506; Osaka:4506). He replaces Christy Shaffer. Inspire was up $0.34 to $6.32 on Friday. ...